A Randomized, Double-blind, Placebo-controlled Phase II Multi-Centre Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and Subcutaneously in Subjects with Acute Ischemic Stroke (ReMEDy Trial).

Project: Research

StatusActive
Effective start/end date25/02/1931/12/19

Keywords

  • Neuroscience
  • Ischaemic stroke
  • Clinical trial
  • Neuroscience
  • Ischaemic stroke
  • Clinical trial
  • Neuroscience
  • Ischaemic stroke
  • Clinical trial